See more : Zoompass Holdings, Inc. (ZPAS) Income Statement Analysis – Financial Results
Complete financial analysis of RepliCel Life Sciences Inc. (RP.V) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of RepliCel Life Sciences Inc., a leading company in the Biotechnology industry within the Healthcare sector.
- Shanghai Mechanical & Electrical Industry Co.,Ltd. (600835.SS) Income Statement Analysis – Financial Results
- Kikusui Holdings Corporation (6912.T) Income Statement Analysis – Financial Results
- Apple Inc. (AAPL.NE) Income Statement Analysis – Financial Results
- FTAC Zeus Acquisition Corp. (ZINGU) Income Statement Analysis – Financial Results
- Formulafirst Limited (FFI.SW) Income Statement Analysis – Financial Results
RepliCel Life Sciences Inc. (RP.V)
About RepliCel Life Sciences Inc.
RepliCel Life Sciences Inc., a regenerative medicine company, focuses on developing autologous cell therapies that treat functional cellular deficits. Its treatments use autologous cell therapy, which isolates an individual's own cells from harvested tissues and growing more in controlled conditions in a laboratory. The company's product candidates include RCT-01 for the treatment of chronic tendinosis; RCS-01 to treat aging and sun damaged skin; and RCH-01 for the treatment of hair loss. It is also developing RCI-02, a dermal injection device. The company has a collaboration and technology transfer agreement with YOFOTO (China) Health Industry Co. Ltd. for establishing a clinical research program to develop and commercialize RCS-01 and RCT-01; and collaboration and technology transfer agreement with Shiseido Company, Limited for establishing a clinical research program for RCH-01. It also has a collaboration research project agreement with the University of British Columbia to build a hair follicle cell data map. RepliCel Life Sciences Inc. is headquartered in Vancouver, Canada.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 353.74K | 353.74K | 353.74K | 353.74K | 353.74K | 121.11K | 0.00 | 0.00 | 0.00 | 0.00 | 4.12M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 4.16K | 5.78K | 6.98K | 0.00 | 0.00 | 0.00 | 0.00 | 367.76K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 353.74K | 353.74K | 353.74K | 353.74K | 353.74K | 121.11K | -4.16K | -5.78K | -6.98K | 0.00 | 4.12M | 0.00 | 0.00 | -367.76K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 0.00% | 0.00% | 0.00% | 0.00% | 100.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 526.43K | 623.96K | 1.15M | 819.40K | 2.20M | 709.26K | 2.54M | 1.12M | 2.32M | 1.94M | 1.56M | 735.17K | 381.76K | 182.49K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 1.21M | 1.13M | 1.51M | 884.70K | 1.08M | 2.15M | 3.45M | 3.17M | 2.73M | 3.27M | 2.18M | 2.97M | 2.88M | 1.79M | 139.44K | 135.21K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 765.10K | 464.81K | 57.35K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 1.21M | 1.13M | 1.51M | 884.70K | 1.08M | 2.15M | 3.45M | 3.17M | 2.73M | 3.27M | 2.18M | 3.73M | 3.34M | 1.85M | 139.44K | 135.21K | 371.13K | 491.31K | 299.92K | 518.98K | 93.96K |
| Other Expenses | 0.00 | 1.20M | -873.42K | -68.49K | -33.29K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 1.74M | 1.75M | 2.65M | 1.68M | 3.28M | 2.86M | 5.99M | 4.29M | 5.05M | 5.21M | 3.74M | 4.47M | 3.73M | 2.04M | 139.44K | 135.21K | 371.13K | 491.31K | 299.92K | 518.98K | 93.96K |
| Cost & Expenses | 1.74M | 1.75M | 2.65M | 1.68M | 3.28M | 2.86M | 5.99M | 4.29M | 5.05M | 5.21M | 3.74M | 4.47M | 3.73M | 2.40M | 139.44K | 135.21K | 371.13K | 491.31K | 299.92K | 518.98K | 93.96K |
| Interest Income | 727.00 | 43.00 | 69.00 | 358.00 | 0.00 | 37.00 | 6.78K | 0.00 | 14.73K | 16.40K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 864.53 | 5.03K | 92.91 | 151.47 | 25.94 |
| Interest Expense | 149.10K | 6.70K | 5.53K | 176.09K | 141.43K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 565.00 | 701.00 | 1.59K | 63.07K | 137.71K | 153.58K | 8.93K |
| Depreciation & Amortization | 1.47K | 839.00 | 1.15K | 1.57K | 2.17K | 3.00K | 4.16K | 5.78K | 6.98K | 7.61K | 6.13K | 6.08K | 7.59K | 6.94K | -219.10K | 35.06K | 463.57K | -526.34K | 111.24K | 885.37K | 9.75K |
| EBITDA | -1.38M | -664.49K | -3.93M | -1.51M | -2.97M | -2.69M | -5.99M | -4.28M | -5.04M | -5.20M | 389.35K | -3.36M | -3.71M | -2.54M | -359.11K | -100.86K | -141.81K | -750.22K | -246.23K | -207.00K | -91.76K |
| EBITDA Ratio | -391.47% | -53.88% | -896.35% | -323.07% | -814.35% | -2,234.66% | 0.00% | 0.00% | 0.00% | 0.00% | 9.44% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | -1.39M | -191.44K | -3.17M | -1.14M | -2.88M | -2.71M | -5.99M | -4.29M | -5.05M | -5.21M | 383.23K | -4.47M | -3.69M | -2.40M | -140.01K | -135.92K | -605.38K | -223.88K | -357.47K | -1.09M | -101.51K |
| Operating Income Ratio | -391.89% | -54.12% | -896.67% | -323.51% | -814.96% | -2,237.13% | 0.00% | 0.00% | 0.00% | 0.00% | 9.30% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | 1.07M | 652.28K | -1.77M | -229.91K | -77.32K | -86.46K | -22.42K | 16.33K | 2.91K | 12.21K | 240.00 | 1.11M | -19.50K | 138.43K | 219.66K | -34.36K | -227.39K | 202.38K | -133.76K | -311.99K | -2.20K |
| Income Before Tax | -311.73K | -743.23K | -4.07M | -1.58M | -3.00M | -2.77M | -6.01M | -4.27M | -5.04M | -5.20M | 383.47K | -3.36M | -3.67M | -2.40M | 79.66K | -170.27K | -601.19K | -290.44K | -491.24K | -1.40M | -103.71K |
| Income Before Tax Ratio | -88.13% | -210.11% | -1,151.52% | -446.74% | -849.27% | -2,286.34% | 0.00% | 0.00% | 0.00% | 0.00% | 9.31% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 0.00 | 1.21M | -867.89K | 183.53K | 44.03K | 29.78K | 22.42K | -16.33K | -2.91K | -12.21K | 412.04K | -1.11M | -239.37K | 0.00 | 0.00 | 0.00 | -233.52K | 325.47K | -63.72K | -419.95K | 1.36K |
| Net Income | -311.73K | -743.23K | -4.07M | -1.58M | -3.00M | -2.77M | -6.01M | -4.27M | -5.04M | -5.20M | -28.57K | -3.36M | -3.49M | -2.40M | 79.66K | -170.27K | -601.19K | -290.44K | -427.52K | -984.40K | -105.07K |
| Net Income Ratio | -88.13% | -210.11% | -1,151.52% | -446.74% | -849.27% | -2,286.34% | 0.00% | 0.00% | 0.00% | 0.00% | -0.69% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | -0.01 | -0.02 | -0.13 | -0.06 | -0.12 | -0.13 | -0.32 | -0.54 | -0.89 | -1.02 | -0.01 | -0.79 | -1.00 | -1.11 | 0.60 | -1.35 | -4.95 | -0.08 | -2.96 | -0.30 | -0.04 |
| EPS Diluted | -0.01 | -0.02 | -0.13 | -0.06 | -0.12 | -0.13 | -0.32 | -0.54 | -0.89 | -1.02 | -0.01 | -0.79 | -1.00 | -1.11 | 0.60 | -1.35 | -4.95 | -0.08 | -2.96 | -0.30 | -0.04 |
| Weighted Avg Shares Out | 59.24M | 37.77M | 32.49M | 26.96M | 24.11M | 21.85M | 18.68M | 7.95M | 5.69M | 5.09M | 4.52M | 4.27M | 3.49M | 2.16M | 125.88K | 125.88K | 121.53K | 3.49M | 144.36K | 3.28M | 2.84M |
| Weighted Avg Shares Out (Dil) | 59.24M | 37.77M | 32.49M | 26.96M | 24.11M | 21.85M | 18.68M | 7.95M | 5.69M | 5.09M | 4.52M | 4.27M | 3.49M | 2.16M | 125.88K | 125.88K | 121.53K | 3.49M | 144.36K | 3.28M | 2.84M |
Source: https://incomestatements.info
Category: Stock Reports